レウコトリエンE4と,喘息患者の呼吸道への粒細胞浸透
L A Laitinen1, A Laitinen, T Haahtela
1Department of Pulmonary Medicine, Helsinki University Central Hospital, Finland.
Lancet (London, England)
|April 17, 1993
まとめ
硫化ドペプチドルキュートリエンは,ルキュートリエンのLTE4と同様に,喘息でエオシノフィルと中性粒子を募集することによって,呼吸道炎症を増加させます. これらのメディエーターをターゲットにすることが,喘息患者にとって抗炎症およびステロイドを節約する利点をもたらす可能性があります.
科学分野:
- 免疫学 免疫学とは
- 肺内科 肺内科 肺内科
- 薬理学 薬理学とは
背景:
- スルフィドペプチドルキュートリエンは強力な支支末管収縮剤である.
- 彼らは,喘息の重要な特徴である,支氣管の過剰反応性を増加させます.
研究 の 目的:
- 呼吸道粘膜の細胞変化を調査するために,喘息患者でルオコトリエンLTE4を吸入した後に.
- 喘息の治療のための硫化ドペプチドルキュートリエンの標的化の可能性を評価する.
主な方法:
- 4人の喘息患者で,ルオコトリエンLTE4を吸入した.
- 吸入後4時間後の呼吸道粘膜生検における炎症性細胞数の分析.
主要な成果:
- レウコトリエンLTE4を吸入すると,呼吸道内膜のエオシノフィルと中性粒子が有意に増加します.
- エオシノフィルの数は中性粒子の約10倍でした.
- リンパ球,プラズマ細胞,マスト細胞,マクロファージにおいて有意な変化は見られなかった.
結論:
- レウコトリエンLTE4は,喘息患者の呼吸道における粒細胞,特にエオシノフィルの強力な募集剤として作用します.
- アンチスルフィドペプチドルキュートリエン薬は,潜在的抗炎症およびステロイドを節約する喘息治療法として調査を正当化します.
関連する概念動画
Asthma-IV: Diagnostic and Management
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Microbiota of the Respiratory Tract
The human respiratory tract, comprising the upper and lower segments, serves as a critical interface with the external environment. The upper respiratory tract (URT)—including the nostrils, sinuses, pharynx, and oropharynx—is heavily colonized by microbes, while the lower respiratory tract (LRT), composed of the larynx, trachea, bronchi, and lungs, was long thought to be sterile. However, recent molecular studies have revealed that the lungs are not devoid of microbes but act more like...
Acute Inflammation II: Cellular Phase
The cellular phase of acute inflammation is a tightly orchestrated sequence of events that recruits leukocytes, primarily neutrophils, to sites of tissue injury or infection. Following the initial vascular changes, this phase ensures effective immune cell migration, activation, and function at the affected site to eliminate pathogens and initiate tissue repair.Leukocyte Recruitment CascadeLeukocyte recruitment happens in four steps: margination, adhesion, transmigration, and chemotaxis. Reduced...
Chronic Inflammation: Introduction
Chronic inflammation is a prolonged, dysregulated immune response that persists for weeks to years when the inciting stimulus is difficult to eradicate or when self‑antigens drive ongoing reactivity. Morphologically, it is defined by mononuclear cell infiltration, progressive tissue destruction, and concurrent attempts at healing via angiogenesis and fibrosis. Compared with acute inflammation, edema is less prominent while cellular infiltration predominates; triggers include persistent...
Chronic Obstructive Pulmonary Disease II: Emphysema
Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...


